Books on the topic 'Non-small cell lung cancer'

T, Carr David, and International Cancer Research Data Bank., eds. Non-small cell lung cancer. Bethesda, MD: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, International Cancer Research Data Bank, 1988.

Ramaswamy, Govindan, ed. Locally advanced non-small-cell lung cancer. Manhasset, NY: CMP United Business Media, 2004.

Seeber, Siegfried, ed. Small Cell Lung Cancer. Berlin, Heidelberg: Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-82372-5.

Recent advances in locally advanced non-small-cell lung cancer. Manhasset, N.Y: CMPMedica, 2006.

Ettinger, David S. The role of chemotherapy in non-small cell lung cancer. Syracuse, NY: Bristol Laboratories Oncology Products, Bristol-Myers Oncology Division, 1986.

1935-, Skarin Arthur T., and Alexander Eben, eds. Multimodality treatment of lung cancer. New York: M. Dekker, 2000.

Jerome, Seidenfeld, Blue Cross and Blue Shield Association. Technology Evaluation Center., and United States. Agency for Healthcare Research and Quality., eds. Management of small cell lung cancer. Rockville, MD: Agency for Healthcare Research and Quality, Public Health Service, U.S. Dept. of Health and Human Services, 2006.

Benjamin, Movsas, Langer Corey J, and Goldberg Melvyn, eds. Controversies in lung cancer: A multidisciplinary approach. New York: M. Dekker, 2001.

author, Bujamma D., and M., Naresh Babu (Muppalaneni), author, eds. Bioinformatics of non small cell lung cancer and the ras proto-oncogene. Heidelberg: Springer-Verlag, 2015.

Carr, David T. Selected abstracts on small cell lung cancer. Bethesda, MD: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1986.

Banerjee, Srabani. Treatment of inoperable advanced non-small-cell lung cancer: Regimens with or without taxane. Ottawa: Canadian Coordinating Office for Health Technology Assessment, 2002.

Kashyap, Amita, D. Bujamma, and Naresh Babu M. Bioinformatics of Non Small Cell Lung Cancer and the Ras Proto-Oncogene. Singapore: Springer Singapore, 2015. http://dx.doi.org/10.1007/978-981-4585-08-8.

IASLC Workshop on Small Cell Lung Cancer (3rd 1989 Helsingør, Denmark). Management of small cell lung cancer: Third IASLC Workshop on Small Cell Lung Cancer, Elsinore, Denmark, 18-22 June, 1989. Edited by Hansen Heine Høi, Kristjansen Paul E. G, and International Association for the Study of Lung Cancer. Amsterdam: Elsevier, 1989.

M, Marangolo, and Fiorentini G, eds. Small cell lung cancer: Proceedings of the International Conference on Small Cell Lung Cancer, 27-28 March 1987, Ravenna, Italy. Oxford: Pergamon Press, 1988.

1948-, Johnson David H., and Klastersky J, eds. Taxanes in lung cancer therapy. New York: Marcel Dekker, 1998.

International Workshop on Small Cell Lung Cancer Antigens (2nd 1990 Royal Society of Medicine). Small cell lung cancer antigens: Proceedings of the Second International Workshop on Small Cell Lung Cancer Antigens held at the Royal Society of Medicine, 25-27 April 1990. [Basingstoke, Hampshire: published for Cancer Research Campaign by Macmillan, 1991.

Small cell carcinomas: Causes, diagnosis and treatment. New York: Nova Biomedical Books, 2009.

Bunn, Paul A. VePesid (etoposide injection), its role in small cell lung cancer. Syracuse, N.Y: Bristol-Myers, Oncology Division, 1985.

McCracken, Joseph D. Concurrent chemotherapy and radiation therapy for limited small cell lung cancer. Syracuse, N.Y: Bristol-Myers, Oncology Division, 1986.

G, Maldonado Jonathon, and Cervantes Mikayla K, eds. Small cell carcinomas: Causes, diagnosis and treatment. Hauppauge, N.Y: Nova Science, 2009.

Maldonado, Jonathon G. Small cell carcinomas: Causes, diagnosis and treatment. New York: Nova Biomedical Books, 2009.

H, Einhorn Lawrence, and Gralla Richard J, eds. Treatment and prevention of small cell lung cancer and non-small cell lung cancer: Proceedings of an international symposium sponsored by Bristol-Myers Oncology Division, held in London, England, 28 August, 1988. London: Royal Society of Medicine Services, 1989.

Young, Sean Steven. Lactic acid transport in small cell lung cancer cell lines NCI-H69 and NCI-H69AR. Sudbury, Ont: Laurentian University Press, 1995.

1940-, Hayat M. A., ed. Lung and breast carcinomas. Amsterdam: Elsevier, Academic Press, 2008.

Tammemagi, Martin Carl. Tobacco smoking, p53 tumour suppressor gene alterations, and clinicopathologic features and prognosis in non-small cell lung cancer. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1998.

Maldonado, Jonathon G., and Mikayla K. Cervantes. Small cell carcinomas: Causes, diagnosis and treatment. New York: Nova Biomedical Books, 2009.

"Lebensqualität" in onkologischen Therapiestudien: Konzepte, Methodik und Anwendung am Beispiel des Kleinzelligen Bronchuskarzinoms. Bern: P. Lang, 1992.

Dubois, Natalie C. Inhibition of small cell lung cancer cell line (H-69) with the calcium channel blocker, Verapamil. Sudbury, Ont: Laurentian University, 1995.

Ross, Jama. Energy metabolism in small cell lung cancer lines H-69 and H-69AR. Sudbury, Ont: Laurentian University, 1995.

National Institute for Clinical Excellence., ed. Guidance on the use of docetaxel, paclitaxel,gemcitabine and vinorelbine for the treatment of non-small cell lung cancer. London: NICE, 2001.

Wake, Beverley. Hyperfractionated-accelerated radiotherapy regimens for the treatment of non-small cell lung cancer: A systematic review of clinical and cost-effectiveness. Birmingham: University of Birmingham, Department of Public Health and Epidemiology, 2002.

Birnkrant, David Jonathan. Small cell cancer of the lung: An initial evaluation of the Yale treatment protocol. [New Haven: s.n.], 1985.

Rogers, M. J. A phenomenological investigation of the patient's experience in the first month following palliative radiotherapy for non-small cell lung cancer. Oxford: Oxford Brookes University, 2000.

Ozog, Mark. The energy metabolism of a small cell lung cancer cell line, H69, and its drug resistant derivative, H69AR. Sudbury, Ont: Laurentian University, Department of Biology, 1995.

Veterinary clinical epidemiology: A problem-oriented approach. 2nd ed. Boca Raton: CRC Press, 1995.

Veterinary clinical epidemiology. 3rd ed. Boca Raton: CRC/Taylor & Francis, 2006.

Smith, Ronald Dee. Veterinary clinical epidemiology: A problem-oriented approach. Boston: Butterworth-Heinemann, 1991.

Mazzuchin, Chris. Inhibition of lactic acid transport in small cell lung cancer H69 by alpha-cyano-3-hydroxycinnamate. Sudbury, Ont: Laurentian University, 1995.

Hann, Brad. The Inhibitory effects of alpha-cyano-4-hydroxycinnamic acid on the lactate transporter of H69 small cell lung cancer cells. Sudbury, Ont: Laurentian University, 1995.

Network, Scottish Intercollegiate Guidelines, ed. The use of palliative radiotherapy in the treatment of non small cell lung cancer: A national clinical guideline recommended for use in Scotland by the Scottish Intercollegiate Guidelines Network. Edinburgh: Scottish Intercollegiate Guidelines Network, 1996.

Andrew, Clegg, National Co-ordinating Centre for HTA (Great Britain), and Health Technology Assessment Programme, eds. A Rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer. Alton: Core Research on behalf of the NCCHTA, 2002.

Plönes, Till. Serum level of CC-chemokine ligand 18 is increased in patients with non-small-cell lung cancer and correlates with survival time in adenocarcinomas. Freiburg: Universität, 2012.

Muldoon, Lori. Glucose, lactate, and lactate dehydrogenase activity of the small cell lung cancer line H-209 and the drug resistant variant H-209/V6. Sudbury, Ont: Laurentian University, 1992.

Moreira, Andre Luis, and Anjali Saqi. Diagnosing non-small cell carcinoma in small biopsy and cytology. New York: Springer, 2015.

Azzoli, Christopher G. Non-Small Cell Lung Cancer. Jones & Bartlett Learning, LLC, 2009.

Non-small cell lung cancer. Bethesda, MD: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, International Cancer Research Data Bank, 1988.

Non-Small Cell Lung Cancer: New Research. Nova Science Pub Inc, 2013.

Fast Facts: Non-Small-Cell Lung Cancer. Karger AG, S., 2022.

Awad, M. M., B. Besse, and M. O'Brien. Fast Facts: Non-Small-Cell Lung Cancer. Karger AG, S., 2022.

Giaccone, Giuseppe. Systemic Treatment of Non-Small Cell Lung Cancer. Oxford University Press, 2012.